Star Health and Allied Insurance Company Limited has informed the exchanges regarding declaration of unaudited standalone financial results of the Company for the quarter and half year ended September 30,2026.

Date: October 27, 2026 Place: Chennai Ref: SHAI/B & S/SE/132/2026-27 To, To, The Manager, The Manager, Listing Department, Listing Department, BSE Limited, National Stock Exchange of India Limited, Phiroze Jeejeebhoy Tower, Exchange Plaza, 5th Floor, Plot C/1, Dalal Street, G Block, Bandra-Kurla Complex, Mumbai – 400051, Mumbai – 400001, Maharashtra, India. Maharashtra, India. Scrip Code: 543412 Symbol: STARHEALTH Dear Sir/ Madam, Sub: Outcome of Board Meeting – October 27, 2026 We wish to inform that the Board of Directors of Star Health and Allied Insurance Company Limited (“Company”), in their meeting held on Tuesday, October 27, 2026 inter alia, had considered and approved the following: 1. Un-audited standalone financial results of the company for the quarter and half year ended September 30, 2026 as per Regulation 30, 33, 51, 52 read with Schedule III Part A and Part B of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“SEBI LODR”) together with the Limited Review Report issued by the Joint Statutory Auditors, M/s. T R Chadha & Co LLP Chartered Accountants and M/s. MSKA & Associates LLP Chartered Accountants. The aforementioned Un-audited standalone financial results, the Limited Review Report, disclosures as required under Regulation 52(4) of the SEBI LODR and a declaration on the utilisation of the issue proceeds of non-convertible securities in accordance with Regulation 52(7)(A) of SEBI LODR for the quarter and half year ended ended September 30, 2026 are enclosed as Annexure 1. 2. Reclassification of Sthitaprajna Advisors LLP from Promoter Group Category to Public Shareholder Category. The Meeting of the Board of Directors of the Company commenced at 11:30 A.M (IST) and concluded at 06.30 P.M. (IST). In compliance with Regulation 46 and 62 of the SEBI LODR, the above information is also being hosted on the Company's website at www.starhealth.in. Kindly take the same on record. For Star Health and Allied Insurance Company Limited Jayashree Sethuraman Company Secretary & Compliance Officer Copy to: IDBI Trusteeship Services Limited, Asian Building, Ground floor, Ballard Estate, Mumbai-400 001, Maharashtra, India. Encl: As above Annexure - 1 STAR H COMPANY with for the Three months Three months Sl. No. Particulars ended September ended June 30, months Half year ended Half Year ended Year ended March 2026 2026 September 30, 2025 September 30, 2026 September 30, 2025 31,2026 I unaudited unaudited unaudited ontracts not measured under the pAA 4.39.578 8.64.085 2 4.39.578 8.64.085 n sc sur sre sd aC nl da im res versals on onerous contracts 3.14.144 6.09.288 (55) 189 2.181 29,389 54.402 3.167 1 L32.653 for cash 1 60 .. 4o 15 72 760\ 2.774 1 t 47 .6 30 e5 2\ 3 4.66.630 9.11.858 16.46.387 IA 4AE\ (8.'197) A 38.629 76.938 R {q7t 1.23.562 (l) lnvestment revenue on financial assets not measured at FVTPL 32.592 30 614 27.323 63 206 55.976 1 14 957 ![er lnvestment revenue n0.725\ f iii) on (91) 64.369 i 504 91 75,152 'l (0) (0) 0 0 /n\ 64.369 9't.126 1.09.076 from 616 130 '168 23.699 46.691 1 1.242 (28.8271 11 35.164 11. 1,23.400 12 35.164 '11.163 59.97t urrent tax 25.046 2.662 13.523 I ;43 4.672 1 54.974 41.454 91.104 Profit / (Loss) from disconlinued oporations (after tax) 16 (14-15) 26.441 81,454 't,,t04 (i) ltems that will not be rectassified to profit or (loss) A (- ii )R le ncm oe ma esu tr ae xn re en lat lio nf g D te of in itee md sB te hn ae t fi wt ilp l la non t reclassified to 147 t41r)\ 147 1410\ r3.786t (1031 r1 03) aq53l (i) ltems that wall be to profit or loss (specify items 1't0 43071 (ii) lncome tax relating to items that reclassified to 110 t307t 19 8t f, ( U rn CORPORATE .O OFFICE Transfor of profit 26,4a1 7 104 14.33.7s3 11 54855 753 'l 14 0't6 8.00.005 7.48.296 55.300 62.890 1 1,33,746 1 'l.13.A27 24.29.255 22 20.79.868 Equity 1't.60.750 13.73.492 58.795 58.840 r.60.323 8.98.972 10.'t4.423 9.1 9.1 I 8 9.57.812 1.35 '15.49 25 per Equity (for discontinued operations) 933 1.35 8.80 15.48 Earnings per Equity Share for profiU(loss) of the period (for 26 discontinued and continuinq ooerationst 4.50 '1.35 13.84 '15.49 4_49 1.35 NA NA NA NA NA ratio NA NA NA 8.03o/o L'170/o 7 o ooo/" 0.000/d o ooo/. 0.000/" 8.22o/o 1A O50t" (viii) Claims Ratio for General lnsurance business and Claims experi€nce ratio for Life lnsurance business 68.95% 68.33% 71 519/" 68.650/" 70 76.0/" 68 a40/" 23.O10/o 23.O10 t? 1eo/" 23.490/. 94.52Vo 92.33o/o 2.57.k 8.140/o 9.990/6 NA NA NA NA Ratio NA NA NA NA 0.00o/o 0.000/o 4 9.56.209 (xix) Percentage of shares trR eta dt io by Gov-nment-FtnaffiEl- o o50l" 0.05% 0.06% of public sector lnsurers NA NA NA Note: 1 Analytical Ratios have been calculated as per the definition gjven by IRDA| . 2 3 T Thh ee CEx op me bn is ne e d R Oat pio e rr ae tp inre gs Ren att is o ln ms eu ara sn uc ree s S lne sr uy rie an cE ex p Se en rs ve ics e (e Ex xc plu ed ni sn eg s c ala s im a - pre el ra @te nd t age ex p€n os f e ls n) s uraa ns c ea p Re erc ve en nt ua eg .e of lnsurance Revenue. 4 The Solvency has been computed at the last day of the period 5 Not Annualized :L oc) CORPORATE OFFICE f IRDAI Circular PailicubB HatrYearended Year ended March 31, 2028 i Revenu€): 5,34,7{9 5,50,780 10,85,5:tO 194 5,02,667 4,80,831 4,34,O20 9,83,498 8,52,970 17,61,673 lncome 17,111 10,484 10.305 57,598 45.080 67,486 314 6E 5 112 84 (1661 4,51 1 4,669 s,268 I,180 10,546 20,617 110 93 396 130 624 2 0 0 3 (2" Revenue 198 161 290 359 569 875 Other lncome 2 0 21 0 ( (2 0: 1. 0 32 0 3 (0 0) 2 Tobl 3E,309 38,629 19,504 75,938 u,111 (A) Heafth lnsurance Seruice Erpenses (5 4, ,0 62 3, ,6 46 77 4) 4,E0,631 (44 ,, 13 01 ,, 00 52 00 1 9,63,49E (88 ,, 05 02 ,, 89 07 80 1 I /,61,573 contacts (2,1 r6) 13,822\t (8,023) 4,511 1,669 5,268 9,180 10,546 20,618 (2.922]. (4,s33) (5,323) (10,61 8) expenses/income confacts (372) 955 (s76) 563 (97) 162) (C) Travel lnsurance Seruice Expenses 198 t6t 290 359 569 E75 1234) (1 13) (321) expenseMncome 50 (8e) 177) 205 3 Total Segment lnsurance Finance Resuft: 26,767 '16,508 75,152 17,111 10,485 10,305 57,598 45,080 67,485 110 288 93 398 {30 621 2 21 (2 30 Segment PrcfiUlo3r: 24,81 7,958 81,454 51,776 91,104 19,535 37,292 s,t69 56,627 32,036 67,568 833 895 (5511 1,728 (1 r0l (1,9531 11 54 17 122 1125) 5 11,7E,897 't0,92,189 9,37,931 rr,7E,897 10,s3,870 11,51,579 10,64,017 9.09,255 I 1,5't,579 9,09,255 10,70,217 25,505 27,185 24,142 26,606 24,142 29,O71 712 582 o R€insuEnce 55,300 52,895 (A) Heah 17,901 50.282 58.869 47,90'l 58,869 57,490 4,563 1,626 4,563 3,783 7E0 392 239 431 239 2tg Note 2 31 S l ln Je nvg 6 am 6 llote m cn aet ts n in lnc rc elu o pd m re 66 e,: n( OA lst) h H he ere .a l ent t ch ho. em ( B e S) aP an re d ec ho O on t la h dt e A E fc urc nDi dd e se n n s at e s, s( 'C w er) h i tT c hr h ea v c IRe at n Dn Ao It Rbe ga ull lo ac tia ot ned to any seqment are apportoned on the basis of Gros Written premium 4 Compadtive figures forthe quarteG/years are resbted on accountof changes in lnteresl fnance e)eenses and.esultant segment allocalion. \s- $, CORPORATE OFFICE Other Disclosuresn status of shareholders complaints for the quarter ended september 30,2026 Sr No Particulars Number No. of Investor at the of 0 2 No. of Investor the eriod 3 No. of Investor off the 0 4 No. of Investor unresolved at the end of the 0 The above disclosure is not required to be audited. D ,&n- F*F- E (-., CORPORAIE C) OFFICE STAR ALLIED Pursuant to of the and ure rements 2015 as am st Particulars Three months Three months Three months Half Year Half Year See pn tede md ber ended 0J 2u 6ne 30, See pn tede md ber See pn tede md ber See pn tede md ber MaY re ca hr 3e 1n ,d 2e 0d 26 30, 2026 30, 2025 30, 2026 30, 2025 unaudited unaudited unaudited unaudited unaudited 1 of 001 0.05 0.05 ool 0.05 005 2 0.88 73 22 11,75 2.65 34 69 30.87 35.23 73.22 '1175 54.22 34.69 30 87 NA NA NA NA NA 5 reserve 4) 't 0 43 573 9'19118 9.19.1'18 g 57 A12 7 Net 54.974 81 455 51. [Showing first 8,000 characters — download PDF for full document]